Lamivudine

interferon alpha 1 ; Homo sapiens







41 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34960758 Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections. 2021 Dec 11 1
2 25911883 Interferon-α combined with lamivudine versus lamivudine monotherapy for the emergence of YMDD mutations in chronic hepatitis B infection: a meta-analysis of randomized controlled trials. 2015 Jan-Feb 1
3 26584037 Recent Advances in the Management of Chronic Hepatitis B Including Suppression of Hepatocellular Carcinoma by Entecavir and Interferon. 2015 1
4 21940341 Anti-viral therapy in chronic HBV infection: a single centre experience. 2011 Sep-Oct 1
5 21186536 [Observation on effect of peg interferon lphaa-2a treating lamivudine resistant chronic hepatitis B]. 2010 Jun 3
6 21319036 Non-response to previous interferon therapy and cirrhosis are risk factors for predicting breakthrough during lamivudine therapy in patients with chronic hepatitis B. 2010 Sep 20 1
7 18364079 [Effects of antiviral agents on intrahepatic ccc DNA in HBeAg-positive chronic hepatitis B patients]. 2008 Mar 4
8 19669298 Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B. 2008 Jun 1
9 17226901 Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment. 2007 Jan 14 1
10 17244247 A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B. 2007 Feb 1
11 17716343 Comparative cost-effectiveness of antiviral therapies in patients with chronic hepatitis B: a systematic review of economic evidence. 2007 Sep 1
12 17958644 Treatment of chronic hepatitis D. 2007 Nov 1
13 16568374 Early reduction of infected hepatocytes by activated immunity at the time of interferon withdrawal hepatitis followed by lamivudine administration resulted in higher seroconversion in hepatitis Be antigen-positive patients with chronic hepatitis B. 2006 Feb 2
14 16688836 Pegylated IFN-alpha 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B. 2006 Apr 21 2
15 17029610 Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine. 2006 Nov 2
16 15720534 Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B. 2005 Mar 2
17 16108170 Treatment of chronic hepatitis B infection using interferon. 2005 Jul 1
18 16118673 Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial. 2005 Aug 2
19 16171525 Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis? 2005 Sep 19 1
20 14635007 Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy. 2004 Jan 1
21 15078472 Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a. 2004 Apr 1
22 15340535 [IFN or oxymatrine in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B]. 2004 Mar 4
23 15504288 [Clinical study of lamivudine and interferon combinate administration to inhibit hepatitis B virus replication]. 2004 Oct 2
24 15510896 [The HBeAg/antiHBe seroconversion as a result of lamivudine treatment in children with chronic hepatitis B unresponsive to previous interferon alpha therapy]. 2004 Jun 2
25 15610309 Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy. 2004 Dec 2
26 12584227 Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase. 2003 Mar 2
27 12753143 Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus. 2003 Jun 1
28 12773249 [Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B]. 2003 May 1
29 12875729 Efficacy of interferon alpha-2b and lamivudine therapy for chronic hepatitis B in children. 2003 Apr 1
30 11966945 Introduction of lamivudine for the treatment of chronic hepatitis B: expected clinical and economic outcomes based on 4-year clinical trial data. 2002 Feb 1
31 12046342 [Lamivudine in patients with chronic HBV infection and therapeutic difficulties]. 2002 Jan 4
32 12121506 Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients. 2002 Jul 2
33 12139566 Alpha interferon and lamivudine combination therapy for chronic hepatitis B in children. 2002 Aug 1
34 12483247 Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy. 2002 2
35 11526544 Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study. 2001 Sep 1
36 11672823 Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug? 2001 Nov 3
37 10689749 [New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?]. 2000 Jan 3
38 10861649 Hepatitis B e antigen seroconversion: effects of lamivudine alone or in combination with interferon alpha. 2000 Jul 1
39 10861651 Lamivudine for hepatitis B in clinical practice. 2000 Jul 2
40 11038017 Lamivudine as an alternative therapy for interferon-resistant chronic hepatitis B and the characteristics of hepatitis B virus: a case report. 2000 Aug 1
41 9623272 [New antiviral agents in the treatment of chronic hepatitis B and C]. 1998 Apr 1